Condition: Non-Small Cell Lung Cancer · Sponsor: Dizal (Jiangsu) Pharmaceutical Co., Ltd.
This study will treat patients with advanced NSCLC harboring EGFR mutations. This is the first study to test DZD6008 combined with sunvozertinib in patients, which will help to understand what type of side effects with the treatment. It will also measure the levels of two drugs in the body and preliminarily assess the anti-tumor activity with the combination treatment
This description comes directly from the study's public registry record.
YIFAN LIU · (86) 021-61095854 · yifan.liu@dizalpharma.com
clinicaltrials@dizalpharma.com · clinicaltrials@dizalpharma.com
Always discuss trial participation with your own doctor first.
| Beijing Chest Hospital | Beijing, Beijing Municipality, China | Recruiting |
| The First Affiliated Hospital of Guangzhou Medical University | Guangzhou, Guangdong, China | Recruiting |
| Harbin Cancer Hospital | Harbin, Heilongjiang, China | Not Yet Recruiting |
| Hunan Cancer Hospital | Changsha, Hunan, China | Not Yet Recruiting |
| Jiangsu People's Hospital | Nanjing, Jiangsu, China | Not Yet Recruiting |
| Nanjing Gulou Hospital | Nanjing, Jiangsu, China | Recruiting |
| The First Hospital of Jilin University | Changchun, Jilin, China | Not Yet Recruiting |
| First Affilicated Hospital of China Medical University | Shengyang, Liaoning, China | Not Yet Recruiting |
| Shandong Cancer Hospital | Jinan, Shandong, China | Recruiting |
| Shanghai Chest Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
| The First Affilicated Hospital of Xi'An Jiaotong University | Xi’an, Shanxi, China | Not Yet Recruiting |
| Sichuan Cancer Hospital | Chengdu, Sichuan, China | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07079475